The synthesis and pharmacological evaluation of (±)-2,3-seco- fentanyl analogues

Journal of the Serbian Chemical Society

Volumn 69, Issue 11, 2004, Pages 955-968

  Ivanovic M D ^a,d   Micovic I V ^a   Vuckovic S ^b   Prostran, M ^b   Todorovic Z ^b   Ivanovic, E R ^b   Kiricojevic V D ^c,d   Djordjevic J B ^b   Dosen Micovic Lj ^b,d  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d SERBIAN CHEMICAL SOCIETY   (Serbia)

Author keywords

1,3 Diamines; Open chain fentanyl analogues; Opioid analgesics

Indexed keywords

EID: 31644433403     PISSN: 03525139     EISSN: 03525139     Source Type: Journal    
DOI: 10.2298/JSC0411955I     Document Type: Article

References (61)

1. ] 1. a) W. Kiefer, G. Dannhardt, Current Opinion in Investigational Drugs, (Pharma Press Ltd.) 3 (2002) 1348.
2. b) A. N. Nitu, R. Wallihan, V. Skiljarevski, N. M. Ramadan, Expert Opinion on Investigational Drugs 12 (2003) 545.
3. c) J. F. Herrero, E. A. Romero-Sandoval, G. Gaitan, J. Mazario, CNS Drug Reviews 9 (2003) 227.
4. d) C. A. Kornick, J. Santiago-Palma, N. Moryl, R. Payne, O. Richard, A. M. T. Eugenie, Drug Safety 26 (2003) 951.
5. e) J. W. Lewis, S. M. Husbands, Current Pharmaceutical Design 10 (2004) 717.
6. f) C. Bountra, R. Munglani, W. K. Schmidt, Pain (2003) 491, Publisher; Marcel Dekker, Inc., New York, N. Y.
7. g) R. B. Raffa, R. Clark-Vetri, R. J. Tallarida, A. I. Wertheimer, Expert Opinion on Pharmacotherapy 4 (2003) 1697.
8. h) M. H. Ossipov, J. Lai, T. W. Vanderah, F. Porreca, Life Sciences 73 (2003) 783.
9. i) A. Gottschalk, C. L. Wu, A. E. Ochroch, Expert Opinion on Pharmacotherapy 3 (2002) 1599.
10. j) M. Williams, E. A. Kowaluk, S. P. Americ, J. Med. Chem. 42 (1999) 1481.
11. th Ed., McGraw-Hill Medical Publishing Division (2001) pp. 569, 687.
12. THE MERCK INDEX, 13. Ed. MERCK & CO. (2001), Inc., NJ, 11996
13. J. D. White, J. Chem. Soc., Chem. Commun. 2002, 1159
14. a) A. F. Casy, R. T. Parfitt, Opioid Analgesics, Plenum Press, N.Y., USA (1986)
15. b) A. F. Casy, Advances in Drug Research, B. Tesla, Ed., 18 (1989) 178, Academic Press, London
16. a) M. D. Ivanović, I. V. Mićović, S. Vučković, M. Prostran, Z. Todorović, V. D. Kricojević, J. B. strok D signordević, Lj. Došen- Mićović, J. Serb. Chem. Soc. 69 (2004) 511;
17. b) V. D. Kiricojević, M. D. Ivanović, I. V. Mićović, J. B. strok D signordević, G. M. Roglić, Lj. Došen-Mićović, J. Serb. Chem. Soc. 67 (2002) 793;
18. c) I. V. Mićović, M. D. Ivanović, S. M. Vučlović, M. Š. Prostran, Lj. Došen- Mićović, V. D. Kricojević, Bioorg. Med. Chem. Lett. 10 (2000) 2011;
19. d) I. V. Mićović, M. D. Ivanović, S. M. Vučković, D. Jovanović-Mićić, D. Beleslin, Lj. Došen-Mićović, V. D. Kiricojević, Heterocyclic Communications 4(1998) 171 and the references cited therein;
20. e) I. V. Moćović, G. M. Roglić, M. D. Ivanović Lj. Došen-Mićović, V. D. Kiricojević, J. B. Popović, J. Chem. Soc., Perkin Trans. l (1996) 2041;
21. f) U. S. Patent 5,489,689 (1996);
22. g) U. S. Patent 4,179,569 (1979);
23. h) Van Daele, M. F. L. De Bruyn, J. M. Boey, S. Sanczuk, J. T. M. Agten, P. A. J. Janssen, Arzneim-Forsch., (Drug Res.) 26 (1976) 1521;
24. i) L. V. Kudzma, S. A. Severnak, M. J. Benvenga, E. F. Ezill, M. H. Ossipov, V. V. Knight, F. G. Rudo, H. K. Spencer, T. C. Spaulding, J. Med. Chem. 32 (1989) 2534;
25. j) M. D. Ivanović, Ph. D. Thesis, Chemistry Dept, University of Belgrade (1998)
26. Online Chemical Abstract search by SciFinder returned several hundred papers and patents, in the period 2000-2004. See for example: a) J. A. Miller, S. A. Pope, D. R. Riddall, G. M. Ullaha, G. M. Welsh, Tetrahedron Lett. 44 (2003) 8411;
27. b) I. J. Kim, T. Ullrich, J. W. Janetka, M. S. Furness, A. E. Jacobson, R. B. Rothman, C. M. Dersch, J. L. Flippen-Anderson, C. George, K. C. Rice, Bioorg.&Med. Chem. 11 (2003) 4761;
28. c) S. Ananthan, N. K. Khare, S. K. Saini, L. E. Seitz, J. L. Bartlett, P. Davis, C. M. Dersch, F. Porreca, R. B. Rothman, E. J. Bilsky, J. Med. Chem. 47 (2004) 1400;
29. d) A.Zhang, W. Xiong, J. M. Bidlack, J. E. Hubert, B. I. Knapp, M. P. Wentland, J. L. Neumeyer, J. Med. Chem. 47 (2004) 165;
30. e) M. Spetea, F. Schullner, R. C. Moisa, I. P. Berzetei-Gurske, B. Schrami, C. Dorfler, M. D. Aceto, L. S. Harris, A. Coop, H. Schmidhammer, J. Med. Chem. (2004) ASAP article;
31. f) Y. Jinsmaa, A. Miyazaki, Y. Fujita, T. Li, Y. Fujisawa, K. Shiotani, Y. Tsuda, T. Yokoi, A. Ambo, Y. Sasaki, S. D. Bryant, L. H. Lazarus, Y. Okada, J. Med. Chem. 47 (2004) 2599;
32. g) F. I. Carroll, L. Zhang, S. W. Mascarella, H. A. Navarro, R. B. Rothman, B. E. Cantrell, D. M. Zimmerman, J. B. Thomas, J. Med. Chem. 47 (2004) 282;
33. h) B. S. Vig, T. F. Murray, J. V. Aldrich, J. Med. Chem. 47 (2004) 446;
34. i) L. Jong, N. Zaveri, L. Toll, Bioorg.&Med. Chem. Lett. 14 (2004) 181;
35. j) US Patent 6645980 B1 (2003)
36. [CA. 2003: 887681];
37. k) WO Patent 2003066050 Al (2003)
38. [CA. 2003:633467];
39. WO Patent 2003064425 Al (2003)
40. [CA. 2003:610453]
41. I. V. Mićović, M. D. Ivanović, V. D. Kiricojević, S. Vučković, Lj. Došen- Mićović, Proceedings of ESCOC-1: The First International Electornic Conference on Synthetic Organic Chemistry, and Proceedings of ECSOC-2; The Second International Electronic Conference on Synthetic Chemistry, Sept. 1-30, 1997, 1998 (1999), Meeting Date 1997-1998, 198-204
42. [CA.: 2001:54887]
43. a) C. Meyer, O. Piva, P. Jean-Pierre, Tetrahedron 56 (2000) 4479;
44. b) J. Cossy, A. Thellend; Synthesis (1989) 753 and the references cited therein;
45. c) M. Labelle, D. J. Gravel, J. Chem. Soc. Chem. Comm. (1985) 105;
46. d) G. E. Utzinger, Helv. Chim. Acta. 35 (1952) 1359;
47. e) C. J. Kibler, A. Weissberger; Org. Synth., Coll. Vol. III (1955) 108;
48. f) C. F. Allen, W. J. Humphlett, Org. Synth., Coll. Vol. IV (1963) 80
49. a) D. Gravel, M. Labelle, Can. J. Chem. 63 (1985) 1874;
50. b) G. A.Reynolds, C. R. Houser, Org. Synth., Coll. Vol. III (1955) 374
51. M. Fujita, T. Hiyama, Org. Synth. 69 (1990) 44
52. a) L. Weiler, J. Am. Chem. Soc. 92 (1970) 6702;
53. b) P. H. Lambert, M. Vaultier, R. Carrie, J. Org. Chem. 50 (1985) 5352
54. a) J. S. Hubbard, T. M. Harris, M. Thomas, Tetrahedron Lett. 47 (1978) 4601;
55. b) A. C. Goudie, H. E. Rosenberg, R. W. Ward, J. Heterocyclic Chemistry 20 (1983) 1027
56. I. V. Mićović, M. D. Ivanović, D. M. Piatak, V. strok D sign. Bojić, Synthesis (1991) 1043
57. 13C-NMR, MS) proved the exclusive enamine structure, rather than the imine or imine/enamine tautomeric mixtures. For the enamine derived from 4-oxo-1-phenethyl-piperidine-3-carboxylic acid methyl ester and aniline see Ref. 5d and for the enamine from 1-phenetyl-piperidine-2,4-dione and aniline see Ref. 5e
58. O. Hutchins, B. E. Maryanoff, Org. Synth. Coll. Vol. VI (1988) 223
59. P. A. J. Janssen, C. J. E. Niemegeers, J. G. H. Dony, Arzneim-Forsch (Drug Res.) 13 (1963) 502
60. nd edition, Springer Verlag, New York, Berlin, Heidelberg, London, Paris, Tokyo, 1986
61. M. Couturier, J. L. Tucker, B. M. Andresen, P. Dube, J. T. Negrin, Org. Lett. 3 (2001) 465.